HIV Clinical Trial
Official title:
Acute HIV Infection - A Key Link for Transmission Prevention: A Randomized Pilot Study
This pilot study will assess the feasibility for the potential public health benefit of
behavioral and antiretroviral interventions during acute HIV infection.
Central Hypothesis The investigators hypothesize that delivering behavioral and
antiretroviral interventions to acutely infected persons will reduce onward transmission.
The HIV epidemic in sub-Saharan Africa is severe and continues to grow. In urban areas of
Malawi, 19% of pregnant women seeking antenatal care and 15.6% of Malawians aged 15-49 years
were infected with HIV in 2007. Prevention interventions that prevent onward transmission of
HIV are urgently needed.
Persons with acute HIV infection (AHI) may be responsible for a substantial proportion of
onward transmission of HIV infection. AHI is characterized by unfettered replication of HIV
in a "ramp up viremia". The high concentration of HIV in blood and genital secretions remains
elevated for up to 10-12 weeks before it declines to the levels observed in established
infection. These high levels of HIV shedding in the genital tract are likely to produce very
efficient sexual transmission and the proportion of virions that are infectious may be
substantially higher during acute compared to chronic infection. Consequently, the
probability of transmission during unprotected intercourse for those with AHI is very high.
Identifying persons with AHI and intervening to reduce onward transmission represents a
tantalizing, but unproven, opportunity for HIV prevention.
To have maximal impact, a prevention program targeting AHI must identify a substantial number
of acutely infected persons and intervene quickly to minimize onward transmission. An
effective immediate intervention would require behavioral modification to limit sexual
partners and unprotected sex acts, and a biological intervention to reduce infectious viral
burden in genital secretions. This is the first study to pilot a combined behavioral and
biomedical intervention in individuals with AHI to reduce onward transmission of HIV.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06162897 -
Case Management Dyad
|
N/A | |
Completed |
NCT03999411 -
Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients
|
Phase 4 | |
Completed |
NCT02528773 -
Efficacy of ART to Interrupt HIV Transmission Networks
|
||
Active, not recruiting |
NCT05454839 -
Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
|
||
Recruiting |
NCT05322629 -
Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women
|
N/A | |
Completed |
NCT02579135 -
Reducing HIV Risk Among Adolescents: Evaluating Project HEART
|
N/A | |
Active, not recruiting |
NCT01790373 -
Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence
|
N/A | |
Not yet recruiting |
NCT06044792 -
The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
|
||
Completed |
NCT04039217 -
Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM
|
Phase 4 | |
Active, not recruiting |
NCT04519970 -
Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK)
|
N/A | |
Completed |
NCT04124536 -
Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women
|
N/A | |
Recruiting |
NCT05599581 -
Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health
|
N/A | |
Active, not recruiting |
NCT04588883 -
Strengthening Families Living With HIV in Kenya
|
N/A | |
Completed |
NCT02758093 -
Speed of Processing Training in Adults With HIV
|
N/A | |
Completed |
NCT02500446 -
Dolutegravir Impact on Residual Replication
|
Phase 4 | |
Completed |
NCT03805451 -
Life Steps for PrEP for Youth
|
N/A | |
Active, not recruiting |
NCT03902431 -
Translating the ABCS Into HIV Care
|
N/A | |
Completed |
NCT00729391 -
Women-Focused HIV Prevention in the Western Cape
|
Phase 2/Phase 3 | |
Recruiting |
NCT05736588 -
Elimisha HPV (Human Papillomavirus)
|
N/A | |
Recruiting |
NCT03589040 -
Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant
|
Phase 2 |